相关实验视频

Updated: Feb 21, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

一个统一的机器学习模型用于临床I期丸癌复发预测

Thomas Wagner¹, Ramtin Zargari Marandi², Jakob Lauritsen³

¹Department of Pathology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Copenhagen, Denmark.

|February 19, 2026

概括

一个新的机器学习模型准确地预测了第一阶段丸癌的复发,而不论亚型. 这种工具对于排除复发是有价值的,特别是在非精子瘤病例中.

科学领域:

在瘤学瘤学.
机器学习机器学习
生物统计学生物统计学

背景情况:

大约25%的临床I期丸癌患者经历了复发.
传统的风险分层使用了有限的变量和单独的模型,用于精卵瘤和非精卵瘤.
机器学习通过分析大型数据集,为新型风险因素的发现提供了潜力.

研究的目的:

开发和验证一个统一的机器学习模型,用于预测临床I期丸癌复发.
创建一个适用于半瘤和非半瘤亚型的模型.
为了提高预测效果,利用全国性的病原体和临床数据.

主要方法:

一项基于人口的队列研究,对1377名患有临床I期丸癌症的患者进行了研究 (2013-2018).
使用基于树的分类器 (CatBoost,LightGBM) 和随机生存森林模型.
数据分为培训 (80%) 和测试 (20%) 集,根据亚型和结果进行平衡.

主要成果:

CatBoost模型实现了0.74的AUC和0.86.8的负预测值.
随机生存森林显示一致性指数为0.71.
关键预测因素包括淋巴血管入侵,瘤缩和生物标志物升高;瘤缩和LVI位置是新的预测因素.

结论:

一个统一的机器学习模型用于预测丸癌复发是可行的,准确度中等.
该模型有效地排除了复发,特别是在非精子瘤中.
结果表明了验证的框架,并突出了未来研究的重要预测特征.

关键词:

临床I阶段的疾病.可以解释的机器学习.预后因素预后因素这是一个复发的复发.风险预测风险预测丸癌症丸癌症是什么

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...